Vyome Holdings (HIND) Total Liabilities (2015 - 2026)
Vyome Holdings (HIND) posted quarterly Total Liabilities of $2.1 million for Q1 2026, down 59.18% year-over-year from $5.3 million in Q1 2025, and down 21.61% quarter-over-quarter from $2.7 million in Q4 2025.
Vyome Holdings (HIND) Total Liabilities (2015 - 2026) Analysis & Trends
Vyome Holdings' Total Liabilities history runs 12 years deep, the most recent figure standing at $2.1 million for Q1 2026.
- In Q1 2026, Total Liabilities fell 59.18% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $2.1 million (down 59.18% YoY), while the FY2025 annual figure was $2.7 million, down 52.62% from the prior year.
- Total Liabilities for Q1 2026 stood at $2.1 million, down from $2.7 million in the prior quarter.
- The five-year high for Total Liabilities was $9.6 million in Q2 2022, with the low at $2.1 million in Q1 2026.
- The 5-year median for Total Liabilities is $4.7 million (2023), against an average of $5.2 million.
- The sharpest annual moves came in 2022 and 2024: Total Liabilities sank 84.52% in 2022, then jumped 44.31% in 2024.
- Vyome Holdings' Total Liabilities stood at $7.5 million in 2022, then tumbled by 46.53% to $4.0 million in 2023, then surged by 44.31% to $5.8 million in 2024, then sank by 52.62% to $2.7 million in 2025, then declined by 21.61% to $2.1 million in 2026.
- Business Quant data shows HIND's Total Liabilities at $2.1 million in Q1 2026, $2.7 million in Q4 2025, and $3.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.20 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.35 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 10.03 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 3.22 Bn |
| 10 | Vyome Holdings | 16.00 Mn | 8.11 Mn | 11,658.00 | 1.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.86 Mn |
| Mar 31, 2026 | 2.14 Mn |
| Dec 31, 2025 | 2.74 Mn |
| Sep 30, 2025 | 3.13 Mn |
| Jun 30, 2025 | 3.20 Mn |
| Mar 31, 2025 | 5.25 Mn |
| Dec 31, 2024 | 5.77 Mn |
| Sep 30, 2024 | 4.13 Mn |
| Jun 30, 2024 | 3.36 Mn |
| Mar 31, 2024 | 3.70 Mn |
| Dec 31, 2023 | 4.00 Mn |
| Sep 30, 2023 | 4.74 Mn |
| Jun 30, 2023 | 5.11 Mn |
| Mar 31, 2023 | 8.59 Mn |
| Dec 31, 2022 | 7.48 Mn |
| Sep 30, 2022 | 7.53 Mn |
| Jun 30, 2022 | 9.58 Mn |
| Mar 31, 2022 | 8.66 Mn |
| Dec 31, 2021 | 8.20 Mn |
| Sep 30, 2021 | 11.48 Mn |